| Literature DB >> 28828019 |
Mohammad Javad Alemzadeh-Ansari1, Mohammad Mostafa Ansari-Ramandi1, Nasim Naderi1.
Abstract
Heart failure (HF) is one of the main causes of death and disability in the world. The prevalence of HF in developed countries is between 1% and 2% of the adult population and approximately between 6% and 10% in the elderly, giving rise to high costs of care and treatment. Indeed, in the United States, the direct and indirect costs exceeded 23 billion dollars in 2002. HF is typically characterized by periods of acute symptoms followed by returns to nearly asymptomatic periods. As dyspnea and fatigue are considered the signature symptoms of HF, other symptoms such as pain go unnoticed. Awareness of the burden of pain, however, is growing in patients with chronic HF. The past 2 decades have witnessed remarkable technical headway in cardiology and many patients have survived despite the progressive impairment of their cardiovascular function. It is, therefore, of great value to investigate the prevalence and management of pain in patients with HF. To that end, we undertook a comprehensive search using the MEDLINE database for studies and guidelines on the subject of pain and HF and the complications and considerations and finally selected 65 studies for review.Entities:
Keywords: Chronic disease; Heart failure; Pain; Review
Year: 2017 PMID: 28828019 PMCID: PMC5558055
Source DB: PubMed Journal: J Tehran Heart Cent ISSN: 1735-5370
Prevalence of pain in patients with heart failure in different studies
| Study | Patient and Study Design | Pain Prevalence | Outcome of Pain | Findings Associated with Increase in Pain |
|---|---|---|---|---|
| Blinderman et al., 2008[ | Outpatients with end-stage CHF | 29% (chest pain or pressure) | High symptom-associated distress being seen in 26.7% of the patients with chest pain and in 54.1% of those with other types of pain | ---- |
| Lip et al., 1997[ | Hospitalized patients (acute HF) | 23.1% (chest pain) | ---- | ---- |
| Whelan et al., 2004[ | In hospitalized patients and in a period of 30 days after discharge | 59% of the total patients | ---- |
Diagnosis-related group weight Age > 65 years Female gender Education level above high school |
| Nordgren and Sörensen, 2003[ | In hospitalized patients (patients with end-stage HF) and in a period of the last 6 months of life) | 75% | ---- | ---- |
| Godfrey et al., 2007[ | Patients with HF at hospital discharge and at 2 and 6 weeks post discharge | At hospital discharge (68%; n: 115) | Decrease in health-related QOL |
Depression Worry Feeling a loss of control over one’s life Feeling as if one was a burden to the family |
| Goebel et al., 2009[ | Veterans with HF | 55.2% | ---- |
Increase in overall symptoms |
| Conley et al., 2015[ | Outpatients with stable HF | 57% | Pain, fatigue, and depression being associated with decreased functional performance | ---- |
| Goodlin et al., 2012[ | Outpatients with advanced HF | 84.4% | ---- |
Degenerative joint disease Other arthritis Shortness of breath Angina pectoris |
| Rustøen et al., 2008[ | Hospitalized patients with HF | 85% | 80% of the patients with HF reporting that pain interfered with their normal work | Higher number of chronic conditions |
| Shah et al., 2013[ | Hospitalized patients (acute decompensation of HF) | 60% | ---- | Lower LVEF (≤ 40%) |
| Udeoji et al., 2012[ | Outpatients with stable HF | 52% | ---- |
Lower LVEF (≤ 40%) |
| Gan et al., 2012[ | Chronic HF at a mean follow-up of 22 months | 25.6% | An increase in MACE (patients with moderate-to-severe pain having higher MACE) |
Increase in NYHA functional class Female gender More comorbidities Lower LVEF Shorter distance during the 6-minute walking test Increase in MLHFQ scores Increase in TNF-α levels |
| Pantilat et al., 2016 | Patients with HF (classes II and III) | 43% | ---- | Depression (even in mild stage) |
| Evangelista et al., 2009[ | Chronic HF | 67% | Decrease in physical and overall QOL | Worsening functional class |
| Bekelman et al., 2007[ | Outpatients with HF | 52% | Number of the symptoms being strongly inversely associated with health status as measured by the KCCQ overall score | ---- |
| Levenson et al., 2000[ | Patients with HF during the last 6 months of life | 41% of the patients’ carers reporting that their patient was in severe pain during the last 3 days before death | Increase in the rate of severe pain in the last 6 months of life | Approach of death |
| Desbiens et al., 1997[ | Seriously ill hospitalized patients | 51.2% of all the patients (not defined as HF) | ---- |
Dyspnea Nausea |
| Desbiens et al., 1997[ | Survivors of serious illnesses at 2 and 6 months after discharge | 63% of the patients having reported pain in the hospital also reporting pain at 6 months post discharge | Level of hospital pain being most strongly associated with later pain | During the post-discharge period: Level of pain during hospitalization Increasing age from 18 to 50 years Depression Increased dependencies in ADLs Comorbidity disorders Poor QOL Anxiety |
| Desbiens et al., 1996[ | Seriously ill hospitalized patients | 49.9% of the total study population | Dissatisfaction with pain control being more likely reported by the patients with: More severe pain Greater anxiety Depression Alteration in mental status Lower reported income More dependency in ADLs More comorbid conditions (especially colon cancer) Increasing anxiety Depression Poor QOL |
CHF, Congestive heart failure; HF, Heart failure; QOL, Quality of life; LVEF, Left ventricular ejection fraction; MACE, Major adverse cardiac events; NYHA, New York Heart Association; MLHFQ, Minnesota Living with Heart Failure Questionnaire; TNF, Tumor necrosis factor; KCCQ, Kansas City Cardiomyopathy Questionnaire; ADLs, Activities of daily living
Factors associated with pain and increased level of pain in patients with heart failure
| 1 | Physical problems and disabilities |
| 2 | Depression, anxiety, and affective disorders |
| 3 | Ischemia (impaired circulation and oxygenation) |
| 4 | Increase in age |
| 5 | Worsening NYHA functional class |
| 6 | Increased dependencies in ADLs |
| 7 | Female gender |
| 8 | Neurohormonal derangement |
| 9 | Sensation and neurological conduction |
| 10 | Cognition and central nervous system processing |
| 11 | Behavior and health literacy |
| 12 | Social support and relationships |
| 13 | Religious, spiritual, and cultural beliefs |
| 14 | Increase in comorbid disorders |
| 15 | Poor QOL |
| 16 | Approach of death |
NYHA, New York Heart Association; ADLs, Activities of daily living; QOL, Quality of life